COMMUNIQUÉS West-GlobeNewswire

Diffusion Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
10/05/2018
Patient screening and enrollment are underway in Phase 3 inoperable GBM brain cancer trial Key U.S. Patent Issued Clinical trial preparations are ongoing for Phase 2 trial with TSC in stroke CHARLOTTESVILLE, Va., May 10 [...]
Calithera Biosciences Reports First Quarter 2018 Financial Results and Recent Highlights
10/05/2018
-Initiated Randomized Phase 2 CANTATA Trial -Presented Preclinical Data at the American Association for Cancer Research SOUTH SAN FRANCISCO, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: [...]
ChromaDex Corporation Reports First Quarter 2018 Financial Results
10/05/2018
- First Quarter 2018 Net Revenues Increased by 95% to $6.6 Million - IRVINE, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ: CDXC ), a science-based, integrated nutraceutical company devoted to [...]
The Joint Corp. Reports First Quarter Financial Results
10/05/2018
- Increases Annual System-Wide Gross Sales 32%, Compared to First Quarter 2017 - - Grows Revenue 29%, Compared to First Quarter 2017 - - Improves Net Loss by $1.4 Million, Compared to First Quarter 2017 - - Posts Third [...]
OrthoPediatrics Supports Third Medical Mission with World Pediatric Project
10/05/2018
WARSAW, Ind., May 10, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, recently participated in the Company’s third medical [...]
Spero Therapeutics Announces First Quarter 2018 Financial Results and Pipeline Update
10/05/2018
Multiple data readouts expected throughout 2018 and SPR994 Phase 3 initiation anticipated around year-end 2018 CAMBRIDGE, Mass., May 10, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset [...]
Caladrius Biosciences Reports 2018 First Quarter Financial Results
10/05/2018
Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage [...]
Codexis Reports First Quarter 2018 Financial Results
10/05/2018
Total revenues increase 76% to $14.0 million on sharply higher R&D revenue Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS [...]
Cancer Genetics to Report First Quarter 2018 Financial Results on May 15, 2018
10/05/2018
Conference call at 8:30 a.m. EDT, Tuesday, May 15, 2018 RUTHERFORD, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular [...]
Alphatec Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
10/05/2018
CARLSBAD, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec,” “ATEC,” or the “Company”) (Nasdaq: ATEC ), a provider of innovative spine surgery solutions with a mission to improve patient lives [...]
Marrone Bio Innovations, Inc. Reports First Quarter 2018 Financial Results
10/05/2018
Company Successfully Completes Series of Comprehensive Capital Raise and Debt Refinancing Transactions, Generating $40 Million in Estimated Net Proceeds and Converting $45 Million of Debt into Equity DAVIS, Calif., May [...]
KemPharm Announces Positive, Topline Results from an Intravenous Human Abuse Potential Trial with KP415 Prodrug; Reports Q1 2018 Results
10/05/2018
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Intravenous Human Abuse Potential Trial with KP415 Prodrug (KP415.A03) Clinical Findings: Following intravenous [...]
Athersys Reports First Quarter 2018 Results
10/05/2018
Management to host conference call at 4:30pm EDT today CLEVELAND, May 10, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX ) announced today its financial results for the three months ended March 31, 2018. [...]
Profound Medical Corp. Announces First Quarter 2018 Financial Results
10/05/2018
TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Iovance Biotherapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
10/05/2018
- Company to Host Conference Call at 4:30pm ET Today - SAN CARLOS, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies [...]
Aduro Biotech to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
10/05/2018
BERKELEY, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the Bank of [...]
Pernix Therapeutics Reports First Quarter 2018 Financial Results
10/05/2018
MORRISTOWN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, announced today its financial results for the three months ended March 31, 2018. [...]
resTORbio Reports First Quarter 2018 Financial Results
10/05/2018
Last patient dosed in Phase 2b trial; topline data now expected in third quarter of 2018 BOSTON, May 10, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on [...]
PotNetwork Holdings, Inc. Sees Revenue Increase Thanks to the Strength of Diamond CBD, Inc.
10/05/2018
Wholly Owned Subsidiary Diamond CBD, Inc. Continues to Dominate the U.S. Domestic Hemp CBD Oil Market FORT LAUDERDALE, Fla., May 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holdings, Inc. (OTC Pink:POTN) On [...]

Pages